South Korea Cancer Vaccines Market Size & Outlook, 2026-2033
The cancer vaccines market in South Korea is expected to reach a projected revenue of US$ 752.1 million by 2033. A compound annual growth rate of 12.4% is expected of South Korea cancer vaccines market from 2026 to 2033.
- Pharmaceuticals
- Vaccines
- Cancer Vaccines Market Outlook
- Vaccines
Revenue, 2025 (US$M)
$295.5
Estimate, 2026 (US$M)
$331.1
Forecast, 2033 (US$M)
$752.1
CAGR, 2026 - 2033
12.4%
Global Market
Related Markets
Prism AI by Grand View ResearchFree to try
Ask a question about the cancer vaccines market
Every figure cited from GVR research
South Korea cancer vaccines market highlights
- The South Korea cancer vaccines market generated a revenue of USD 295.5 million in 2025 and is expected to reach USD 752.1 million by 2033.
- The South Korea market is expected to grow at a CAGR of 12.4% from 2026 to 2033.
- In terms of segment, recombinant cancer vaccines was the largest revenue generating technology type in 2025.
- Viral Vector and DNA Cancer Vaccines is the most lucrative technology type segment registering the fastest growth during the forecast period.
Cancer vaccines market data book summary
| Market revenue in 2025 | USD 295.5 million |
| Market revenue in 2033 | USD 752.1 million |
| Growth rate | 12.4% (CAGR from 2026 to 2033) |
| Largest segment | Recombinant cancer vaccines |
| Fastest growing segment | Viral Vector and DNA Cancer Vaccines |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Viral Vector and DNA Cancer Vaccines, Other Technologies, Recombinant Cancer Vaccines, Whole-cell Cancer Vaccines |
| Key market players worldwide | Merck & Co Inc, GSK PLC, Dynavax Technologies, Ferring, Amgen Inc, Moderna Inc, Sanofi SA, AstraZeneca PLC, Bristol-Myers Squibb Co |
Other key industry trends
- In terms of revenue, South Korea accounted for 3.0% of the global cancer vaccines market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China cancer vaccines market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,340.8 million by 2033.
No credit card required*
Publish Date: Feb 03, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Vaccines Market Scope
Cancer Vaccines Market segmentation & scope
Cancer Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Amgen Inc | View profile | 26,700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | www.amgen.com |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| Bristol-Myers Squibb Co | View profile | 34,100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | www.bms.com |
| GSK PLC | View profile | 70,200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | www.gsk.com |
| AstraZeneca PLC | View profile | 89,900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | www.astrazeneca.com |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | www.ferring.com |
| Moderna Inc | View profile | 5,600 | 200 Technology Square, Cambridge, MA, United States, 02139 | www.modernatx.com |
| Dynavax Technologies | View profile | 501-1000 | Berkeley, California, United States, North America | www.dynavax.com |
South Korea Cancer Vaccines Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cancer Vaccines Market Outlook will help companies and investors design strategic landscapes.
Recombinant Cancer Vaccines was the largest segment with a revenue share of 63.05% in 2025.
Horizon Databook has segmented the South Korea cancer vaccines market based on viral vector and dna cancer vaccines, other technologies, recombinant cancer vaccines, whole-cell cancer vaccines covering the revenue growth of each sub-segment from 2021 to 2033.
- South Korea Cancer Vaccines Market Technology Type Outlook (Revenue, USD Million , 2021-2033)
- Viral Vector and DNA Cancer Vaccines
- Other Technologies
- Recombinant Cancer Vaccines
- Whole-cell Cancer Vaccines
- South Korea Cancer Vaccines Market Vaccine Type Outlook (Revenue, USD Million , 2021-2033)
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccines
- Other Vaccine Type
- South Korea Cancer Vaccines Market Indication Type Outlook (Revenue, USD Million , 2021-2033)
- Other Indications Type
- Prostate Cancer
- Melanoma
- Cervical
- Bladder Cancer
Reasons to subscribe to Cancer Vaccines Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Cancer Vaccines Market Outlook databook
- Our clientele includes a mix of Cancer Vaccines Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea Cancer Vaccines Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Korea Cancer Vaccines Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
South Korea Cancer Vaccines Market, 2021-2033 (US$M)
South Korea cancer vaccines market statistics, by technology type, 2021-2033 (US$M)
